Search

Search Constraints

You searched for: Author/Creator Schwaab, Juliana

Search Results

1. Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto‐oncogene, receptor tyrosine kinase (KIT) D816V mutations. (1st June 2021)

2. Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia‐associated myeloproliferative neoplasms. Issue 12 (10th September 2015)

3. Identification and functional characterization of imatinib‐sensitive DTD1‐PDGFRB and CCDC88C‐PDGFRB fusion genes in eosinophilia‐associated myeloid/lymphoid neoplasms. Issue 5 (12th February 2014)

4. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis. (21st March 2016)

5. Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis. Issue 5 (19th February 2018)

6. KITD816V and JAK2V617F mutations are seen recurrently in hypereosinophilia of unknown significance. Issue 9 (14th August 2015)

7. Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study. Issue 3 (March 2021)

8. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes. Issue 1 (19th October 2022)

9. Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1‐JAK2, BCR‐JAK2 and ETV6‐ABL1 fusion genes. Issue 7 (28th April 2020)

10. Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis. Issue 16 (1st June 2022)